Infectious Diseases (except HIV/AIDS)
-
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
This article has 21 authors:Reviewed by ScreenIT
-
Viral loads and profile of the patients infected with SARS‐CoV‐2 Delta, Alpha, or R.1 variants in Tokyo
This article has 15 authors:Reviewed by ScreenIT
-
Spatial simulation of COVID-19 new cases development
This article has 2 authors:Reviewed by ScreenIT
-
Association of inflammatory markers with severity of disease and mortality in COVID-19 patients: a systematic review and meta-analysis
This article has 6 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
This article has 47 authors:Reviewed by ScreenIT
-
Blood biochemical parameters as predictors of disease severity and mortality in COVID-19 patients- an updated systematic review and meta-analysis
This article has 6 authors:Reviewed by ScreenIT
-
Characterisation of the blood RNA host response underpinning severity in COVID-19 patients
This article has 105 authors:Reviewed by ScreenIT
-
EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL
This article has 26 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
SARS-CoV-2 Variants in Paraguay: Detection and Surveillance with an Economical and Scalable Molecular Protocol
This article has 16 authors:Reviewed by ScreenIT
-
Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants
This article has 9 authors: